Trial Profile
A phase I/II proof-of-concept study of FP-045
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 02 Aug 2018
Price :
$35
*
At a glance
- Drugs FP-045 (Primary)
- Indications Fanconi's anaemia; Peripheral arterial disorders
- Focus Proof of concept; Therapeutic Use
- 02 Aug 2018 New trial record